Evidence map›Paper›PMID 30718247›Full record

ArticleAntimicrobial agents and chemotherapy2019

Cefepime Pharmacokinetics in Critically Ill Pediatric Patients Receiving Continuous Renal Replacement Therapy.

Gideon Stitt, Jennifer Morris, Lindsay Schmees, Joseph Angelo, Ayse Akcan Arikan

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. A Pilot Study of Cefepime and Meropenem Therapeutic Drug Monitoring in Pediatric Patients on Extracorporeal Therapy.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cefepime Extraction by Extracorporeal Life Support Circuits.The journal of extra-corporeal technology · 2022
    Article
  12. Article
  13. A Review of Extended and Continuous Infusion Beta-Lactams in Pediatric Patients.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2022
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gideon StittDepartment of Pharmacy Services, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA stittg@email.chop.edu.ORCID 0000-0001-5269-214X
Jennifer MorrisDepartment of Pharmacy Services, Texas Children's Hospital, Houston, Texas, USA.
Lindsay SchmeesDepartment of Pharmacy Services, Texas Children's Hospital, Houston, Texas, USA.
Joseph AngeloDepartment of Pediatrics, Renal Section, Baylor College of Medicine, Houston, Texas, USA.
Ayse Akcan ArikanDepartment of Pediatrics, Renal Section, Baylor College of Medicine, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective study included pediatric intensive care unit patients receiving continuous veno-venous hemodiafiltration (CVVHDF) being treated with cefepime. The free drug concentration above one time the MIC (

Indexed as

Continuous Renal Replacement TherapyAcute Kidney InjuryAnti-Bacterial AgentsCefepimeChild, PreschoolCritical IllnessDrug MonitoringFemaleHumansInfantIntensive Care Units, PediatricMaleRetrospective StudiesAnti-Bacterial AgentsCefepimeintensive care unitspediatricspharmacodynamicspharmacokineticsrenal replacement therapy

Identifiers

PMID30718247
PMCPMC6437530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.